NCT04708847View on ClinicalTrials.gov

A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

June 3, 2022

Study Completion Date

February 1, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

GYM329

GYM329 subcutaneous injection

DRUG

Placebo

Placebo subcutaneous injection

Trial Locations (1)

9713

QPS Netherlands B.V., Groningen

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY

NCT04708847 - A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer | Biotech Hunter | Biotech Hunter